Our research is used by government agencies, foundations, and others to advance better health policies and programs.
This report provides an estimate of the non-retail component of drug spending in 2018.
US insulin prices are the highest in the world and unaffordable for millions of American. Our policy roadmap shows how to address this problem.
This month's analysis shows that national health spending continued to rebound in June, and health care regained half of jobs lost in spring, although the pace of recovery has slowed.
This month’s Health Sector Economic Indicators Briefs show a rebound in health care spending and jobs, and varied price effects from the Covid-19 pandemic.
These monthly briefs analyze the most recent data available on health sector employment, spending, prices, and utilization—helping to fill gaps in the official government data.
This report finds that the key differences in price are due to the governance of the dominant insurer, Blue Cross Blue Shield of Michigan.
Health spending deceleration continues; Covid-19 impact is still to come. This report covers February 2020 data, before main Covid-19 effects. See more on health spending, price, and labor growth for April.